M E Ryan1, L M Golub. Show Affiliations » 1. Department of Oral Biology and Pathology, School of Dental Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA.
Abstract
Entities: Disease
Mesh: See more » Alveolar Bone Loss/drug therapyAlveolar Bone Loss/enzymologyAnimalsChelating Agents/therapeutic useClinical Trials as TopicEnzyme InductionExtracellular Matrix/metabolismHumansHydroxamic Acids/therapeutic useMatrix Metalloproteinase InhibitorsMatrix Metalloproteinases/metabolismPeriodontitis/drug therapyPeriodontitis/enzymologyProtease Inhibitors/therapeutic useTetracyclines/therapeutic useUp-Regulation
Substances: See more » Chelating AgentsHydroxamic AcidsMatrix Metalloproteinase InhibitorsProtease InhibitorsTetracyclinesMatrix Metalloproteinases
Year: 2000 PMID: 11276869 DOI: 10.1034/j.1600-0757.2000.2240111.x
Source DB: PubMed Journal: Periodontol 2000 ISSN: 0906-6713 Impact factor: 7.589